-
Patient PerspectivesProstate cancer and support of the care partner – Carl and Arlene’s story
When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
Patient Perspectives -
People and CultureA scientist from the start – Q&A with NIBR President Fiona Marshall
People and Culture -
People and CultureIn neuroscience, “an inflection point in knowledge and technology”
People and Culture -
Patient PerspectivesLet’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero
Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.
Patient Perspectives -
Access to HealthcareRenewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to Healthcare -
Access to HealthcareSickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to Healthcare -
DiscoveryA shared mission to take on the “impossible” in cancer research
Discovery -
Access to HealthcareProstate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Access to Healthcare -
DiscoveryHow Emily’s act of bravery inspired a wave of continued innovation
Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
Discovery -
Access to HealthcareBoosting access to cancer care where it’s needed most
Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.
Access to Healthcare -
Access to HealthcareStaying one step ahead of the malaria parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to Healthcare -
Access to HealthcareTackling the health toll of climate change
Access to Healthcare